Where does E-Therapeutics PLC rank among US patent assignees?

According to USPTO PatentsView (2015–2025 granted utility patents), E-Therapeutics PLC ranks #46,346 of 49,997 assignees by granted-patent volume, the same sort as the companies listing and top-holders ranking. See /methodology/#corpus-placement.

How many patents does E-Therapeutics PLC hold?

E-Therapeutics PLC holds 5 US utility patents granted between 2015 and 2025, spanning 12 technology areas.

What is E-Therapeutics PLC's Innovation Score?

E-Therapeutics PLC has an Innovation Score of 29.7 out of 100 (32nd percentile of the corpus). This composite metric weighs portfolio volume (40%), grant velocity (20%), technology breadth (25%), and claim depth (15%).

What technology areas does E-Therapeutics PLC focus on?

E-Therapeutics PLC's top technology area is C07D (Heterocyclic Compounds) with 3 patents. Grants appear in 12 CPC subclasses total.

Is E-Therapeutics PLC's patent grant rate increasing or decreasing?

E-Therapeutics PLC's recent grant velocity is -67% compared to the prior five-year period (grant years, not application filing dates). Grant activity has slowed relative to earlier years.

What does claim depth mean for E-Therapeutics PLC's patents?

E-Therapeutics PLC's patents average 18.8 claims each. This is an aggregate descriptive count from the grant record; it does not establish claim scope, legal strength, enforceability, or design-around risk.

How is the E-Therapeutics PLC patent data sourced?

All patent data comes from USPTO PatentsView, a public research dataset maintained by the United States Patent and Trademark Office covering US granted utility patents from 2015 to 2025.

USPTO 2015–2025 USPTO PatentsView Foreign Corporation

E-Therapeutics PLC

USPTO PatentsView assignee record - 5 granted patents across 12 technology areas, recorded in grant years 2015–2025. Grant-trend analysis is cross-referenced to USPTO Patent Public Search; it does not measure application filings, current R&D, or legal strength. Primary class: C07D (Heterocyclic Compounds).

Compiled by PlainPatent · May 15, 2026

RSS updates for this company

Explore the portfolio See the ranking

The verdict

According to USPTO PatentsView, E-therapeutics ranks #46,346 of 49,997 tracked US assignees by granted-patent volume, with 5 patents across 12 technology areas.

#46,346
of 49,997 US assignees by volume: 32nd percentile
by Innovation Score (29.7/100): 18.8
avg claims per patent: -67%
grant velocity, last 5 yrs

USPTO PatentsView assignee plate

Corpus R46346 · Foreign Corporation #46,346 · 5 grants

GRANTS-MICRO · BOTTOM-DECILE · PHOTO-FINISH · CPC-FOCUS · INNOV-THIN · CLAIMS-RICH · TYPE-FRNCORP · VEL-DROP · BOOK-FULL

GRANTS-MICRO 5 grants
BOTTOM-DECILE #46,346/49,997
PHOTO-FINISH Dätwyler Schweiz
CPC-FOCUS C07D · 12 areas
INNOV-THIN 29.7/100
CLAIMS-RICH 18.8 claims/avg
TYPE-FRNCORP Foreign Corp
VEL-DROP -67% vel
BOOK-FULL 10/10 fields

Nearest grant-volume peer: Dätwyler Schweiz AG (±0 grants)

Instrument codes from this assignee’s USPTO PatentsView grant sheet: volume band, corpus rank, photo-finish peer, lead CPC, Innovation Score, claim depth, assignee type, velocity, and book completeness. Not a USPTO rating of patent strength.

Qualcomm Incorporated · highest

85
E-Therapeutics · this assignee

30
3D Lighting… · lowest

7

What this shows E-therapeutics's Innovation Score is 29.7/100 (32nd percentile of the PatentsView-derived corpus). The chart places that score against the nearest Innovation Score peers plus corpus poles, not a reprint of the volume ranking.

Where E-therapeutics's grants concentrate

E-Therapeutics PLC is a focused PatentsView assignee: 12 CPC subclasses with 60% of grants classified under C07D (Heterocyclic Compounds). Peak complete grant year is 2015 (2 grants) versus a trough of 1 in 2019. By volume, E-therapeutics sits between Dynisma Ltd. and E.V.S. Ltd..

Dynisma

5
Dätwyler Schweiz

5
E-best Holding

5
E-radio USA

5
E-valve Systems

5
E D Etnyre &

5
E K Licensing

5
E V S

5
E-therapeutics ◀

5

What this shows E-Therapeutics holds 5 patents at rank #46,350, shown against the 8 assignees closest to it in grant volume rather than the industry's largest filers.

Companies ranked near E-Therapeutics

By rank, the assignees closest to #46,350 in granted patent volume.

Leaders in C07D (Heterocyclic Compounds)

Other assignees with the most granted patents in E-Therapeutics's primary technology class.

E-therapeutics's Innovation Score vs. every tracked assignee

Composite of portfolio volume, grant velocity, technology breadth, and claim depth (0–100)

30 32nd percentile higher than 32% of 49,997 US assignees

Each bar is a band; taller bars hold more US assignees. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count, share, and where it sits relative to this entry.

Source USPTO PatentsView, PlainPatent Innovation Score · 2015–2025

USPTO utility patent grants by year · 2015–2025

Grants by year

Teal-shaded recent years (2020–present) versus the 2015–2019 baseline. Full figures in the table below.

View data table

E-Therapeutics PLC patent grants by year, 2015–2025
Year	Patents Granted	Share of Period
2015	2	40.0%
2019	1	20.0%
2021	1	20.0%
2025partial year	1	20.0%

Which technologies does E-Therapeutics PLC patent most?

C07D - Heterocyclic Compounds 3

G06F - Electric Digital Data Processing 1

G06Q - Information AND Communication Technology [ICT] Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory PURPOSES; Systems OR Methods Specially Adapted FOR Administrative, Commercial, Financial, Managerial OR Supervisory Purposes, NOT Otherwise Provided FOR 1

C07F - Acyclic, Carbocyclic OR Heterocyclic Compounds Containing Elements Other Than Carbon, Hydrogen, Halogen, Oxygen, Nitrogen, Sulfur, Selenium OR Tellurium 1

C07B - General Methods OF Organic CHEMISTRY; Apparatus Therefor 1

C07C - Acyclic OR Carbocyclic Compounds 1

Y02P - Climate Change Mitigation Technologies IN THE Production OR Processing OF Goods 1

A61P - Specific Therapeutic Activity OF Chemical Compounds OR Medicinal Preparations 1

G16B - Bioinformatics, i.e. Information AND Communication Technology [ICT] Specially Adapted FOR Genetic OR Protein-related Data Processing IN Computational Molecular Biology 1

C07H - SUGARS; Derivatives THEREOF; NUCLEOSIDES; NUCLEOTIDES; Nucleic Acids 1

C12N - Microorganisms OR ENZYMES; Compositions THEREOF; Propagating, Preserving, OR Maintaining MICROORGANISMS; Mutation OR Genetic ENGINEERING; Culture Media 1

A61K - Preparations FOR Medical, Dental OR Toiletry Purposes 1

Top 12 of 12 technology areas

Where it ranks

Overall rank by patents

#46,346

of 49,997 tracked assignees

Innovation Score

29.7 out of 100

View all rankings →

Data Source

USPTO PatentsView, US granted patents 2015–2025

How is Innovation Score calculated?

What to do with this data

E-Therapeutics PLC's patent record in context - here's where to go next.

E-Therapeutics PLC's lead technology class is C07D (Heterocyclic Compounds), 60% of its portfolio - see every assignee active in that class. Explore C07D
Ranked #46,346 of 49,997 tracked assignees by patent volume - see the full leaderboard. See the ranking
Compare E-Therapeutics PLC against Dynisma Ltd., an assignee filing at a similar volume. Compare portfolios
Innovation Score of 29.7/100 blends volume, velocity, technology breadth, and claim depth. How it's calculated

Figures reflect USPTO PatentsView grant data through May 2026; pending applications not yet granted are not counted.

Data sourced from USPTO PatentsView - official U.S. government patent data. See our methodology for computation details. Retrieved and formatted by PlainPatent

Disclaimer: This information is provided for informational purposes only and does not constitute professional advice. Data is sourced from the USPTO PatentsView database. Consult a qualified professional before making decisions based on this data.

Read our methodology - how this data is sourced, computed, and verified.

Data sources used on this page

USPTO PatentsView - the disambiguated bulk patent-grant, assignee, and CPC data this page's figures are derived from. patentsview.org
Cooperative Patent Classification (CPC) - the joint USPTO/EPO classification scheme used to group patents by technology area. cooperativepatentclassification.org
USPTO Patent Public Search - the official interface to verify the status of any individual patent. ppubs.uspto.gov

Compiled by PlainPatent, US Patent Intelligence Editorial Process · May 15, 2026

Every figure on PlainPatent is rendered directly from USPTO source data, no number is typed in by an editor. This page draws directly on USPTO source data, no figure is typed in by an editor. See our editorial standards & corrections policy, the methodology behind these numbers, or report a data error. Data current as of May 2026.